
Ankylosing spondylitis (AS) is a chronic inflammatory condition that primarily affects the spine. It causes pain, stiffness, and inflammation in the joints and ligaments of the spine, particularly in the lower back and pelvis. Over time, the inflammation can cause the vertebrae to fuse together, leading to reduced flexibility and, in severe cases, a forward-curved posture.
AS is part of a broader group of conditions called spondyloarthritis. While it mainly affects the spine, it can also affect other joints such as the hips and shoulders, as well as other parts of the body including the eyes, skin, and bowel.
There is no cure for ankylosing spondylitis, but with the right treatment many people are able to manage their symptoms and maintain a good quality of life.
Ankylosing spondylitis affects approximately 1 in 200 Australians. Symptoms typically begin between the ages of 15 and 45, with most people first experiencing symptoms in their late teens or 20s. It is about three times more common in males than females, though it can affect anyone.
AS is often underdiagnosed – because lower back pain is common, it can take several years from the onset of symptoms to receive a confirmed diagnosis.
Symptoms of AS tend to come and go and can vary in severity. A key feature that distinguishes AS from mechanical back pain is that symptoms typically worsen with rest and improve with physical activity.
Common symptoms include:
Symptoms that have lasted more than three months and are accompanied by morning stiffness and night pain should be assessed by a doctor.
The exact cause of ankylosing spondylitis is not fully understood. It is believed to involve a combination of genetic and environmental factors:
AS is not contagious and cannot be passed from person to person.
There is no single test for ankylosing spondylitis. Diagnosis is based on a combination of:
If AS is suspected, your GP should refer you to a rheumatologist for specialist assessment. Early diagnosis matters – treatment started before significant joint damage occurs leads to better long-term outcomes.
Treatment aims to reduce inflammation, manage pain and stiffness, maintain spinal mobility, and prevent or slow joint damage.
Exercise and physiotherapy Regular exercise is one of the most important parts of managing AS. Physiotherapy-guided exercises that focus on posture, flexibility, and spinal mobility are recommended for all people with AS. Hydrotherapy and swimming are particularly beneficial.
Self-care Quitting smoking is strongly advised – smoking accelerates spinal damage in AS. Maintaining a healthy weight and managing stress also help with symptom control.
NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen or naproxen are the first-line treatment for AS, reducing inflammation and pain. Regular use is often recommended in active disease rather than as-needed dosing.
Corticosteroid injections may be used for targeted short-term relief in specific inflamed joints.
Conventional DMARDs (disease-modifying anti-rheumatic drugs) such as methotrexate or sulfasalazine are less effective for spinal AS but may be used when peripheral joints are affected.
When NSAIDs or cDMARDs don't provide adequate control, biologic DMARDs are used. These target specific immune pathways driving inflammation and must be prescribed by a rheumatologist. Types include TNF-alpha inhibitors and IL-17 inhibitors.
JAK inhibitors (Janus kinase inhibitors) are oral medications targeting specific immune pathways, used when other treatments have been insufficient.
The following specialty medications are available at Ace, a specialty pharmacy for Ankylosing Spondylitis.
Biosimilars of adalimumab, etanercept, and infliximab are also available on the PBS. Speak with your Ace pharmacist about your options.
With Ace, you’ll benefit from:
Take control of your health and well-being, and start your journey to better health with Ace today.
There are many organisations that support Australians living with ankylosing spondylitis. See below for a selection.